Last Updated: November 5, 2026

VERAPAMIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Verapamil patents expire, and what generic alternatives are available?

Verapamil is a drug marketed by Mylan, Rising, Abraxis Pharm, Aspiro, Bedford, Eugia Pharma, Fresenius Kabi Usa, Gland, Heritage, Hospira, Intl Medication, Knack, Luitpold, Mankind Pharma, Marsam Pharms Llc, Smith And Nephew, Solopak, Zydus Pharms, Amneal, Caplin, Exela Pharma, Micro Labs, Nephron, Somerset, Somerset Theraps Llc, Apotex Corp, Cadila Pharms Ltd, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Pliva, Strides Pharma Intl, Sun Pharm Inds Inc, Zydus Lifesciences, Actavis Elizabeth, Chartwell Rx, Mutual Pharm, Sun Pharm Industries, Warner Chilcott, and Watson Labs. and is included in sixty-eight NDAs.

The generic ingredient in VERAPAMIL is verapamil hydrochloride. There is one drug master file entry for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Verapamil

A generic version of VERAPAMIL was approved as verapamil hydrochloride by EXELA PHARMA on March 30th, 1984.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for VERAPAMIL?
  • What are the global sales for VERAPAMIL?
  • What is Average Wholesale Price for VERAPAMIL?

US Patents and Regulatory Information for VERAPAMIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 073168-001 Jul 31, 1992 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Nephron VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 213352-001 Mar 17, 2020 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Exela Pharma VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 018925-001 Mar 30, 1984 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 071489-001 Jan 13, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Cadila Pharms Ltd VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 206173-003 Nov 14, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rising VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 074587-003 Sep 9, 1997 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Somerset Theraps Llc VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 211015-002 Jun 18, 2018 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.